ES2072928T3 - Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular. - Google Patents

Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.

Info

Publication number
ES2072928T3
ES2072928T3 ES90102179T ES90102179T ES2072928T3 ES 2072928 T3 ES2072928 T3 ES 2072928T3 ES 90102179 T ES90102179 T ES 90102179T ES 90102179 T ES90102179 T ES 90102179T ES 2072928 T3 ES2072928 T3 ES 2072928T3
Authority
ES
Spain
Prior art keywords
cells
iddm
ica
antigens
molecular cloning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90102179T
Other languages
English (en)
Inventor
Daniel Rabin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2072928T3 publication Critical patent/ES2072928T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

ANTIGENOS DE CELULAS DE ISLOTES DE LANG. PANCREATICOS (ICA) QUE SE ASOCIAN CON ANTICUERPOS ENCONTRADOS EN EL SUERO DE PACIENTES AFECTADOS DE DIABETES (IDDM) DEPENDIENTE DE INSULINA (TIPO I). LAS PROTEINAS ICA SE EXPRESAN MEDIANTE VEHICULOS DE CLONES RECOMBINADOS COMPRENDIENDO INSERCIONES AISLADAS DE DNA DE CELULAS DE ISLOTES DE L. SECUENCIAS COMPLETAS DE PROTEINAS ICA NATIVAS, O PROTEINAS, O FRAGMENTOS DE PEPTIDAS DE ELLAS, SE PUEDEN USAR EN EL DIAGNOSTICO DE LA IDDM, Y EN DETECCION O BLOQUEO DE INMUNOGLOBULINA HUMANA, CELULAS T, O CELULAS B INCLUIDAS EN IDDM.
ES90102179T 1989-02-17 1990-02-03 Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular. Expired - Lifetime ES2072928T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US44170389A 1989-12-04 1989-12-04

Publications (1)

Publication Number Publication Date
ES2072928T3 true ES2072928T3 (es) 1995-08-01

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90102179T Expired - Lifetime ES2072928T3 (es) 1989-02-17 1990-02-03 Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.

Country Status (14)

Country Link
EP (1) EP0383129B1 (es)
JP (1) JP2858467B2 (es)
AT (1) ATE122394T1 (es)
AU (1) AU626636B2 (es)
CA (1) CA2010275C (es)
DE (1) DE69019190T2 (es)
DK (1) DK0383129T3 (es)
ES (1) ES2072928T3 (es)
FI (1) FI103730B1 (es)
GR (1) GR3017019T3 (es)
IE (1) IE66997B1 (es)
IL (1) IL93397A (es)
NO (1) NO306996B1 (es)
PT (1) PT93166B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
ATE268908T1 (de) 1990-09-07 2004-06-15 Univ California Verfahren zur diagnose und behandlung von diabetes
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
AU8864791A (en) * 1990-10-02 1992-04-28 Trigen Incorporated Antibodies and methods for diagnosis and treatment of diabetes
CA2103159A1 (en) * 1991-05-15 1992-11-16 Ake Lernmark Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
EP0627934A4 (en) * 1992-02-27 1997-01-08 Univ Leland Stanford Junior EARLY ANTIGEN FOR AUTOIMMUNE DIABETE.
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
JP2001527403A (ja) * 1997-04-25 2001-12-25 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE53862T1 (de) * 1982-01-22 1990-06-15 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
EP0229782B1 (en) * 1985-06-14 1992-11-04 Bristol-Myers Squibb Company Methods for identifying alleles associated with increased risk of diabetes
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
WO1988010120A1 (en) * 1987-06-24 1988-12-29 Brigham And Women's Hospital Treatment of autoimmune diseases by oral administration of autoantigens

Also Published As

Publication number Publication date
PT93166A (pt) 1990-08-31
PT93166B (pt) 1997-11-28
AU626636B2 (en) 1992-08-06
CA2010275A1 (en) 1990-08-17
FI900759A0 (fi) 1990-02-15
EP0383129B1 (en) 1995-05-10
IE66997B1 (en) 1996-02-21
CA2010275C (en) 2000-08-29
FI103730B (fi) 1999-08-31
JP2858467B2 (ja) 1999-02-17
EP0383129A3 (en) 1991-07-31
DE69019190T2 (de) 1995-09-14
IL93397A (en) 1997-06-10
NO900474L (no) 1990-08-20
NO306996B1 (no) 2000-01-24
JPH0347133A (ja) 1991-02-28
EP0383129A2 (en) 1990-08-22
FI103730B1 (fi) 1999-08-31
NO900474D0 (no) 1990-02-01
ATE122394T1 (de) 1995-05-15
GR3017019T3 (en) 1995-11-30
DK0383129T3 (da) 1995-10-09
IE900589L (en) 1990-08-17
DE69019190D1 (de) 1995-06-14
AU4988390A (en) 1990-08-23
IL93397A0 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
ATE87655T1 (de) Markierer der t-zelle aktivierung.
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
DE68925226D1 (de) Monoklonale Antikörper
DE59010450D1 (de) Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
ATE87487T1 (de) Rekombinante hiv-2 polypeptide.
EP0293827A3 (en) Assay for leishmaniasis
WO1992007939A3 (en) Polypeptide with 46kd hmfg differentiation antigen binding specificity
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 383129

Country of ref document: ES